Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer (NCT07104149) | The First Affiliated Hospital of Zhengzhou University | 2025-03-10 |
Track Histologically Confirmed Cervical Cancer, FIGO Stage IB3, IIA2, IIB, IIIC, and Assessed by the Researcher as Resectable Lesion automatically
Every clearance here is in the API, with alerts when new ones post.